Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-28T21:09:18.300Z Has data issue: false hasContentIssue false

Association between COVID-19 testing uptake and mental disorders among adults in US post-secondary education, 2020–2021

Published online by Cambridge University Press:  27 September 2022

Yusen Zhai*
Affiliation:
Department of Human Studies, The University of Alabama at Birmingham, Birmingham, Alabama, USA
Xue Du
Affiliation:
Department of Food Science, The Pennsylvania State University, University Park, Pennsylvania, USA. The work described in the paper was carried out at the University of Alabama at Birmingham, USA
*
Correspondence: Yusen Zhai. Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Summary

Fear and uncertainty have worsened mental health outcomes during the COVID-19 pandemic. COVID-19 testing is essential yet underutilised, and many people may experience difficulties accessing testing if the US federal government fails to sustain the testing capacity. To date, limited evidence exists about the role of COVID-19 testing in mental health. We examined the associations of COVID-19 testing uptake with certain mental disorders, through a nationally representative cohort of adults in US post-secondary education (N = 65 360). Adults with test-confirmed COVID-19 were at significantly lower risk than those with unconfirmed COVID-19 for severe depression, severe anxiety, eating disorders, and suicidal ideation. Findings suggest another potential benefit of public health efforts to encourage COVID-19 testing, namely promoting mental health.

Type
Short report
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists

Testing is an effective yet underutilised means of managing the transmission of COVID-19.Reference Du, Wang, Bai, Wang, Pandey and Fitzpatrick1,Reference Manabe, Sharfstein and Armstrong2 In the USA, it has been difficult to get COVID-19 tests for much of the pandemic,Reference Manabe, Sharfstein and Armstrong2 and many individuals may again experience difficulties obtaining testing after shortages if the US federal government can no longer sustain COVID-19 testing capacity without sufficient funding from Congress.3 Fear and uncertainty fuelled by COVID-19 among public and healthcare workers have worsened mental health outcomes, overwhelming and exhausting the healthcare system.Reference Mollica and Fricchione4Reference El-Sadr and Shea6 Despite the current growing body of knowledge of testing and neuropsychiatric symptoms associated with COVID-19,Reference Boldrini, Canoll and Klein7,Reference Taquet, Geddes, Husain, Luciano and Harrison8 limited evidence exists about the role of COVID-19 testing in mental health outcomes; namely, whether individuals with test-confirmed COVID-19 are less susceptible to certain mental disorders compared with those with unconfirmed COVID-19. In the current study, we hypothesised that COVID-19 testing uptake was significantly associated with severe depression, severe anxiety, eating disorders, and suicidal ideation.

Method

We analysed data from the Healthy Minds Network, which surveyed a random sample of individuals 18 years and older from 140 US colleges and universities (including non-degree programmes) from 9 September 2020 to 24 May 2021. Sample weights were used to adjust non-response based on institutional data on biological sex, race/ethnicity, academic level, and grade point average. Primary outcomes included severe depression symptoms (≥15 on the Patient Health Questionnaire-9), severe anxiety symptoms (≥15 on the Generalised Anxiety Disorder-7 questionnaire), eating disorders (≥3 on the Sick, Control, One, Fat, Food (SCOFF) questionnaire), and suicidal ideation (‘yes’ on ‘In the past year, did you ever seriously think about attempting suicide’). We categorised participants into four groups based on their responses: group 1 (reference group), COVID-19 diagnosis confirmed by testing; group 2, physician-diagnosed COVID-19 without testing; group 3, experienced symptoms consistent with COVID-19 without testing; and group 4, no COVID-19 symptoms. We performed sample-weighted multivariable logistic regression analysis to compute adjusted odds ratios (aORs) and 95% confidence intervals, adjusting for covariates. Based on previous studies,Reference Arango, Dragioti, Solmi, Cortese, Domschke and Murray9,Reference Jia, Ayling, Chalder, Massey, Gasteiger and Broadbent10 covariates included: (a) demographic variables, i.e. age, in years; sex (i.e. female, male, other (intersex)); gender (e.g. woman, man, trans); race/ethnicity (e.g. Black/African American, Asian, Latinx (individuals of Latin American origin or descent), White); disability; international (i.e. international student on a temporary, non-immigrant US visa); relationship status (e.g. single, in a relationship, married); residence (e.g. on-campus, off-campus); and (b) plausible risk factors for mental disorders, i.e. chronic disease (e.g. diabetes, hypertension), smoking and vaping status, and history of diagnosed mental disorder (e.g. clinical depression, anxiety, psychosis). A two-sided P < 0.05 was considered statistically significant.

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human participants were approved by the institutional review board (IRB-300008474) of the University of Alabama at Birmingham. Written informed consent was obtained from all participants.

Results

The current study included 65 360 participants (mean age 24.2 years, s.d. = 8.2 years; 57.7% women). The supplementary Table available at https://doi.org/10.1192/bjo.2022.580 presents participants’ demographics. The prevalence of severe depression, severe anxiety, eating disorders, and suicidal ideation were 21.2%, 16.4%, 11.7%, and 13.5% respectively. Fig. 1 presents the risk factors for these primary outcomes.

Fig. 1 Associations of mental disorders with demographics, chronic diseases, and COVID-19 testing uptake among adults in post-secondary education in the USA, 2020–2021. ref, reference; International, international student on a temporary, non-immigrant US visa.

Participants with physician-diagnosed COVID-19 but unconfirmed by testing (group 2) (aOR = 1.42, 95% CI 1.27–1.59, P < 0.001) and those with suspected COVID-19 without testing (group 3) (aOR = 1.33, 95% CI 1.23–1.45, P < 0.001) were significantly more likely to suffer severe depression compared with those with test-confirmed COVID-19 (group 1).

Participants with physician-diagnosed COVID-19 but unconfirmed by testing (group 2) (aOR = 1.43, 95% CI 1.27–1.61, P < 0.001) and those with suspected COVID-19 without testing (group 3) (aOR = 1.24, 95% CI 1.14–1.35, P < 0.001) were significantly more likely to suffer severe anxiety compared with those with test-confirmed COVID-19 (group 1) .

Participants with physician-diagnosed COVID-19 but unconfirmed by testing (group 2) (aOR = 1.16, 95% CI 1.01–1.32, P = 0.030) and those with suspected COVID-19 without testing (group 3) (aOR = 1.13, 95% CI 1.03–1.25, P = 0.013) were significantly more likely to suffer eating disorders compared with those with test-confirmed COVID-19 (group 1).

Participants with physician-diagnosed COVID-19 but unconfirmed by testing (group 2) (aOR = 1.15, 95% CI 1.01–1.32, P = 0.036) and those with suspected COVID-19 without testing (group 3) (aOR = 1.33, 95% CI 1.21–1.46, P < 0.001) were significantly more likely to have suicidal ideation compared with those with test-confirmed COVID-19 (group 1).

Significant differences were found in severe anxiety and eating disorders but not in severe depression or suicidal ideation between participants without COVID-19 symptoms (group 4) and those with test-confirmed COVID-19 (group 1).

Discussion

To our current knowledge, this is the first national study to examine associations between COVID-19 testing uptake and mental disorders. These findings support our hypothesis that adults with test-confirmed COVID-19 were at significantly lower risk for severe depression, severe anxiety, eating disorders and suicidal ideation compared with those with suspected or physician-diagnosed COVID-19 unconfirmed by testing. These findings corroborate previous research indicating that individuals who suspected that they had COVID-19 but lacked confirmatory testing were more susceptible to exacerbated mental health problems due to fear of infection.Reference Quadros, Garg, Ranjan, Vijayasarathi and Mamun11,Reference Alimoradi, Ohayon, Griffiths, Lin and Pakpour12 These findings suggest that testing may help adults with COVID-19-like symptoms to reduce the risk for mental distress associated with the fear and uncertainty of infection and consequent restrictions.

Additionally, we found no significant difference in risk for severe depression and suicidal ideation between adults with test-confirmed COVID-19 and those without COVID-19 symptoms. Considering that studies suggest COVID-19 infection increases the risk for neuropsychiatric symptoms,Reference Boldrini, Canoll and Klein7,Reference Taquet, Geddes, Husain, Luciano and Harrison8 we conclude that testing may help attenuate the risk for severe depression and suicidal ideation exacerbated by COVID-19 symptoms. Significant differences found in severe anxiety and eating disorders between these two groups might be due to COVID-19 infection rather than testing.Reference Boldrini, Canoll and Klein7,Reference Taquet, Geddes, Husain, Luciano and Harrison8 Some people with a history of COVID-19 infection might suffer long-term physical and mental sequelae of the disease (‘long COVID’) and adverse effects of medications treating infections, which could fuel excessive worry and dysregulate eating behaviours/patterns.Reference Yuan, Zheng, Wang, Sun, Gong and Huang13,Reference Sikaroudi, Zonooz, Ebrahimi, Jebraili, Farsi and Talebi14 These findings suggest that mental health professionals should be ready to address individuals’ mental health problems that develop after COVID-19 illness. To prevent mental disorders associated with severe infection, mental health professionals should also encourage preventive measures (e.g. testing, vaccination) and promote people's health literacy.Reference Brewer and Abad15

This study has limitations. First, the generalisability may be limited because participants represented adults enrolled in post-secondary education. Although our sample showed a wide age range (18–65+ years), the majority were young adults. Older adults may have different levels of fear and tolerance of uncertainty regarding COVID-19. Future studies might examine the role of testing uptake in mental health across different populations/settings. Moreover, causal inferences should be interpreted with caution in this study as cross-sectional data restricted our ability to determine the temporal order between testing uptake and mental disorders that were measured simultaneously. Longitudinal studies are therefore needed to help assess the temporal links. Despite these limitations, this study provides empirical evidence for the associations between COVID-19 testing uptake and mental disorders through a large representative cohort, controlled for covariates to reduce possible confounding effects.

This study underscores the vital role of mental health professionals in public health, providing preliminary support for another potential benefit of public health efforts to encourage COVID-19 preventive measures,Reference Brewer and Abad15 namely promoting mental health. When coupled with other public health measures, timely COVID-19 testing can reduce the transmission of SARS-CoV-2 extensively and can also reduce the risk for severe depression, severe anxiety, eating disorders and suicidal ideation. Our findings suggest that encouraging COVID-19 testing and making testing more accessible will lessen the strain of the pandemic on our healthcare systems and public mental health, particularly during any resurgence of COVID-19 infections.

Acknowledgements

We thank the Healthy Minds Network team for providing access to data. We gratefully acknowledge Jeremy Sandberg for his feedback on the draft of this manuscript, and Scott Snyder for his contribution to statistical analysis.

Supplementary material

Supplementary material is available online at https://doi.org/10.1192/bjo.2022.580.

Data availability

The data that support the findings of this study are openly available on request from the Healthy Minds Network at https://healthymindsnetwork.org.

Author contributions

Y.Z. conceived of the idea and conducted the literature review and data analysis. Both authors contributed to the final manuscript.

Funding

None.

Declaration of interest

None.

References

Du, Z, Wang, L, Bai, Y, Wang, X, Pandey, A, Fitzpatrick, MC, et al. Cost-effective proactive testing strategies during COVID-19 mass vaccination: a modelling study. Lancet Reg Health Am 2022; 8: 100182.Google ScholarPubMed
Manabe, YC, Sharfstein, JS, Armstrong, K. The need for more and better testing for COVID-19. JAMA 2020; 324: 2153–4.CrossRefGoogle ScholarPubMed
The White House. Fact Sheet: Consequences of Lack of Funding for Efforts to Combat COVID-19 if Congress Does Not Act [statements and releases]. The White House, 2022 (https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/15/fact-sheet-consequences-of-lack-of-funding-for-efforts-to-combat-covid-19-if-congress-does-not-act/).Google Scholar
Mollica, RF, Fricchione, GL. Mental and physical exhaustion of health-care practitioners. Lancet 2021; 398: 2243–4.CrossRefGoogle ScholarPubMed
Hadjistavropoulos, T, Asmundson, GJG. COVID stress in older adults: considerations during the omicron wave and beyond. J Anxiety Disord 2022; 86: 102535.CrossRefGoogle ScholarPubMed
El-Sadr, WM, Shea, S. Is omicron showing us the path ahead? Am J Public Health 2022; 112: 562–3.CrossRefGoogle ScholarPubMed
Boldrini, M, Canoll, PD, Klein, RS. How COVID-19 affects the brain. JAMA Psychiatry 2021; 78: 682–3.CrossRefGoogle ScholarPubMed
Taquet, M, Geddes, JR, Husain, M, Luciano, S, Harrison, PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021; 8: 416–27.CrossRefGoogle ScholarPubMed
Arango, C, Dragioti, E, Solmi, M, Cortese, S, Domschke, K, Murray, RM, et al. Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas. World Psychiatry 2021; 20: 417–36.CrossRefGoogle ScholarPubMed
Jia, R, Ayling, K, Chalder, T, Massey, A, Gasteiger, N, Broadbent, E, et al. The prevalence, incidence, prognosis and risk factors for symptoms of depression and anxiety in a UK cohort during the COVID-19 pandemic. BJPsych Open 2022; 8(2): e64.CrossRefGoogle Scholar
Quadros, S, Garg, S, Ranjan, R, Vijayasarathi, G, Mamun, MA. Fear of COVID 19 infection across different cohorts: a scoping review. Front Psychiatry 2021; 12: 708430.CrossRefGoogle ScholarPubMed
Alimoradi, Z, Ohayon, MM, Griffiths, MD, Lin, CY, Pakpour, AH. Fear of COVID-19 and its association with mental health-related factors: systematic review and meta-analysis. BJPsych Open 2022; 8(2): e73.CrossRefGoogle ScholarPubMed
Yuan, K, Zheng, YB, Wang, YJ, Sun, YK, Gong, YM, Huang, YT, et al. A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Mol Psychiatry [Epub ahead of print] 6 Jun 2022. Available from: https://doi.org/10.1038/s41380-022-01638-z.Google ScholarPubMed
Sikaroudi, MK, Zonooz, SR, Ebrahimi, Z, Jebraili, H, Farsi, F, Talebi, A, et al. Assessment of anorexia and weight loss during the infection and recovery period of patients with coronavirus disease 2019 (COVID-19). Clin Nutr Open Sci 2021; 40: 102–10.CrossRefGoogle Scholar
Brewer, NT, Abad, N. Ways that mental health professionals can encourage COVID-19 vaccination. JAMA Psychiatry 2021; 78: 1301–2.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1 Associations of mental disorders with demographics, chronic diseases, and COVID-19 testing uptake among adults in post-secondary education in the USA, 2020–2021. ref, reference; International, international student on a temporary, non-immigrant US visa.

Supplementary material: File

Zhai and Du supplementary material

Zhai and Du supplementary material

Download Zhai and Du supplementary material(File)
File 30.1 KB
Submit a response

eLetters

No eLetters have been published for this article.